Drug Profile
Edonerpic - FUJIFILM Toyama Chemical
Alternative Names: Edonerpic maleate - FUJIFILM Toyama Chemical; T-817 MALatest Information Update: 31 Oct 2023
Price :
$50
*
At a glance
- Originator Toyama Chemical
- Developer FUJIFILM Toyama Chemical; Toyama Chemical
- Class Antidementias; Neuroprotectants; Small molecules; Vascular disorder therapies
- Mechanism of Action Amyloid beta-protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Alzheimer's disease; Stroke
Most Recent Events
- 26 Apr 2022 Edonerpic is still in phase-II trials for Stroke in Japan (JapicCTI-194711) (FUJIFILM Toyama Chemical pipeline, April 2022)
- 26 Apr 2022 Edonerpic is still in phase-II trials for Alzheimer's disease in Netherlands, Germany, Spain and Hungary (PO) (EudraCT2018-003567-66) (FUJIFILM Toyama Chemical pipeline, April 2022)
- 06 Aug 2019 Phase-II clinical trials in Stroke in Japan (PO)